KRISTIN KENNEDY: Open Payments
NPI 1518137843 · FLORENCE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,216 in 54 payments from 18 companies in 2025. Trend: 2023 $817 · 2024 $788 · 2025 $1,216
Food & beverage: $1,007Education: $208
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $246 |
| Janssen Biotech, Inc. | 6 | $210 |
| ABBVIE INC. | 11 | $173 |
| Incyte Corporation | 4 | $93 |
| Novartis Pharmaceuticals Corporation | 4 | $81 |
| Regeneron Healthcare Solutions, Inc. | 3 | $61 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
| Galderma Laboratories, L.P. | 3 | $45 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $44 |
| Almirall LLC | 1 | $37 |
Products named: TREMFYA, ILUMYA, SKYRIZI, OPZELURA, DUPIXENT, RINVOQ, Sotyktu, NEMLUVIO.
Industry payments across KY — which companies pay providers there.
